Back

Results - Announcements

Sales rise 1093.94% to Rs 3.94 crore

Venmax Drugs & Pharmaceuticals standalone net profit declines 85.90% in the March 2026 quarter

15-May-2026, 07:34
Net profit of Venmax Drugs & Pharmaceuticals declined 85.90% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 0.78 crore during the previous quarter ended March 2025. Sales rose 1093.94% to Rs 3.94 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.25 crore in the year ended March 2026 as against net loss of Rs 0.01 crore during the previous year ended March 2025. Sales rose 890.12% to Rs 8.02 crore in the year ended March 2026 as against Rs 0.81 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	3.94	0.33	1094	8.02	0.81	890
OPM %	0.51	-72.73	-	1.50	-129.63	-
PBDT	0.11	0.78	-86	0.28	0	0
PBT	0.11	0.78	-86	0.28	-0.01	LP
NP	0.11	0.78	-86	0.25	-0.01	LP